General & Plastic Surgery Devices - Japan

  • Japan
  • The projected revenue in the General & Plastic Surgery Devices market market in Japan is expected to reach US$1.56bn in 2024.
  • It is anticipated that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 5.82%, leading to a market volume of US$2.07bn by 2029.
  • When compared globally, the United States is projected to generate the highest revenue of US$9,844.00m in 2024.
  • Japan is experiencing a surge in demand for advanced plastic surgery devices, driven by the country's high beauty standards and technological advancements in the medical field.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The General & Plastic Surgery Devices market in Japan is witnessing significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the General & Plastic Surgery Devices market in Japan are driving the growth of the industry. Japanese consumers are increasingly seeking cosmetic procedures to enhance their physical appearance and boost their self-confidence. The desire for beauty and youthfulness has led to a surge in demand for plastic surgery devices such as breast implants, facial fillers, and liposuction equipment. Additionally, the aging population in Japan is also contributing to the growth of the market, as older individuals are more likely to undergo plastic surgery procedures to combat the signs of aging. Trends in the market are also playing a crucial role in the development of the General & Plastic Surgery Devices market in Japan. Technological advancements in surgical devices have made plastic surgery procedures safer and more effective, attracting a larger number of consumers. The introduction of minimally invasive techniques has also gained popularity, as they offer shorter recovery times and reduced scarring. Furthermore, the increasing popularity of non-surgical procedures, such as Botox and dermal fillers, is driving the demand for related devices in the market. Local special circumstances in Japan contribute to the growth of the General & Plastic Surgery Devices market. Japan has a strong healthcare infrastructure and a highly skilled workforce, which enables the country to provide high-quality plastic surgery services. The presence of renowned plastic surgeons and clinics in Japan has attracted both domestic and international patients, further boosting the demand for plastic surgery devices. Additionally, the Japanese government has implemented regulations to ensure the safety and efficacy of medical devices, which has instilled consumer confidence in the market. Underlying macroeconomic factors also contribute to the growth of the General & Plastic Surgery Devices market in Japan. The country has a stable economy and a high disposable income, allowing individuals to afford plastic surgery procedures. Furthermore, the increasing awareness and acceptance of plastic surgery in Japanese society have led to a shift in cultural attitudes, making cosmetic procedures more socially acceptable. These factors, combined with the growing influence of social media and celebrity culture, have fueled the demand for plastic surgery devices in the market. In conclusion, the General & Plastic Surgery Devices market in Japan is experiencing significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The desire for beauty and youthfulness, technological advancements, strong healthcare infrastructure, and a stable economy are driving the development of the market. As the demand for plastic surgery procedures continues to rise, the market is expected to witness further growth in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)